Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

P Azurmendi

4PUBLICATIONS

28CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jul 10, 2024

Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities.

Brian J Mog, Nikita Marcou, Sarah R DiNapoli

|Sep 07, 2021

Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens.

Michael S Hwang, Michelle S Miller, Puchong Thirawatananond

|Mar 02, 2021

Targeting a neoantigen derived from a common <i>TP53</i> mutation.

Emily Han-Chung Hsiue, Katharine M Wright, Jacqueline Douglass

|Mar 02, 2021

Bispecific antibodies targeting mutant <i>RAS</i> neoantigens.

Jacqueline Douglass, Emily Han-Chung Hsiue, Brian J Mog

Pageof 1

Frequent Collaborators

4 joint publications

Jacqueline Douglass

4 joint publications

Brian J Mog

4 joint publications

Sarah R DiNapoli

4 joint publications

Alexander H Pearlman

4 joint publications

Michelle S Miller

4 joint publications

Katharine M Wright

4 joint publications

Nickolas Papadopoulos

4 joint publications

Suman Paul

4 joint publications

Sandra B Gabelli

4 joint publications

Maximilian F Konig

Frequent Collaborators

4 joint publications

Jacqueline Douglass

4 joint publications

Brian J Mog

4 joint publications

Sarah R DiNapoli

4 joint publications

Alexander H Pearlman

Top Related Videos

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on : Nov 12, 2019

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on : Jan 03, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

See more related videos

Top Related Videos

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on : Nov 12, 2019

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Generation of Human Chimeric Antigen Receptor Regulatory T Cells

Published on : Jan 03, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on : Jul 25, 2020

See more related videos